News, Analysis & Insights on Nutrition, Supplements, and Health
The recent journal paper that claimed fish oil may increase the risk of prostate cancer is ‘one of the craziest articles I’ve read’, says GNC CEO Joe Fortunato, who says fish oil is ‘the most clinically tested, scientifically-based product we sell’.
Fonterra has teamed up with the International Osteoporosis Foundation (IOF) to fund research to examine the prevalence of low bone mineral density (BMD) among young women in Indonesia.
€13bn Belgian supplier Solvay has sold its Solactis nutrition division that includes galactofructose (lactulose) to its former nutrition programme manager.
The use of dietary supplements by an estimate 2.9 million US children is ‘moderate and appropriate’, according to a new survey.
Yohimbe plant extracts are unlikely to gain sale in Europe after the European Food Safety Authority (EFSA) found this week the available data was too weak to allow it to pass a safety verdict.
Supplementation with omega-3 and omega-6 could help to boost eye health for people who suffer with dry eye, according to new RCT data.
Supplementation with an extract from Ginkgo biloba may help to battle memory loss and cognitive impairments associated with dementia by encouraging the growth and development of neural stem cells, according new research in rats.
The Food and Drug Administration has enough tools to police the dietary supplement sector. That was the reaction from industry in the wake of yet another negative story about the product category in a high profile publication, in this case, USA Today.
California-based Phytochem International has entered into an agreement to become exclusive North American distributor for Indian botanical extract manufacturer Phytotech PVT LTD.
The National Advertising Division (NAD) has advised global nutricosmetic company New Nordic to modify or discontinue claims for its 'Hair Volume' supplement that suggests the use of the product could reverse hair loss in women.